To verify the observations on these bioinformatic analyses, we accessed the IHC staining of C9orf16 on benign and tumor slides from patients with PDAC and PDAC tumors showed significantly elevated C9orf16 protein levels (Fig. 3F and Fig. 3G). This evidence concerns the gene BBLN and neoplasm.